RhumbLine Advisers
ENZN

RhumbLine Advisers’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

RhumbLine Advisers’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-54,945
Closed -$57K – 3118
2014
Q1 		$57K Sell
54,945
-1,840
-3% -$1.9K ﹤0.01% 2961
2013
Q4 		$66K Sell
56,785
-3,300
-5% -$5.08K ﹤0.01% 2990
2013
Q3 		$101K Sell
60,085
-337
-0.6% -$624 ﹤0.01% 2932
2013
Q2 		$121K Buy
+60,422
New +$177K ﹤0.01% 3197

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RhumbLine Advisers's ENZN Position: Q2 2014 in Review

RhumbLine Advisers sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2014, closing a stake of 54,945 shares — an estimated $57K sold.

RhumbLine Advisers first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $121K in Q2 2013. 67 funds tracked by Wall St. Rank hold ENZN as of Q2 2014.

  • RhumbLine Advisers reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • RhumbLine Advisers sold 54,945 ENZON PHARMACEUTICALS INC shares in Q2 2014, an estimated $57K.
  • RhumbLine Advisers first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • RhumbLine Advisers's ENZON PHARMACEUTICALS INC position peaked at $121K in Q2 2013.
  • 67 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2014.

Based on RhumbLine Advisers's 13F filing for Q2 2014, filed 6 Aug 2014.